BPG
9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE
Find entries where: BPG
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE |
Identifiers | 9-(4-hydroxybutyl)-2-phenylazanyl-1H-purin-6-one |
Formula | C15 H17 N5 O2 |
Molecular Weight | 299.328 |
Type | NON-POLYMER |
Isomeric SMILES | c1ccc(cc1)NC2=Nc3c(ncn3CCCCO)C(=O)N2 |
InChI | InChI=1S/C15H17N5O2/c21-9-5-4-8-20-10-16-12-13(20)18-15(19-14(12)22)17-11-6-2-1-3-7-11/h1-3,6-7,10,21H,4-5,8-9H2,(H2,17,18,19,22) |
InChIKey | JHBXNPBKSPYOFT-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 39 |
Chiral Atom Count | 0 |
Bond Count | 41 |
Aromatic Bond Count | 11 |
Drug Info: DrugBank
DrugBank ID | DB02495 |
---|---|
Name | 9-(4-hydroxybutyl)-N2-phenylguanine |
Groups | experimental |
Description | 9-(4-hydroxybutyl)-N2-phenylguanine is a solid. This compound belongs to the hypoxanthines. These are compounds containing the purine derivative 1H-purin-6(9H)-one. 9-(4-hydroxybutyl)-n2-phenylguanine is known to target thymidine kinase. |
Synonyms |
|
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Thymidine kinase | MASYPCHQHASAFDQAARSRGHSNRRTALRPRRQQEATEVRLEQKMPTLL... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 135415618, 5287832, 448110 |
ChEMBL | CHEMBL406254 |